Progyny (NASDAQ: PGNY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.010 | 0.050 | 0.0400 | ||||
REV | 166.230M | 172.217M | 5.987M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Progyny (NASDAQ: PGNY) through any online brokerage.
Other companies in Progyny’s space includes: Humana (NYSE:HUM), HealthEquity (NASDAQ:HQY), Tekla World Healthcare (NYSE:THW), Molina Healthcare (NYSE:MOH) and Alignment Healthcare (NASDAQ:ALHC).
The latest price target for Progyny (NASDAQ: PGNY) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 60.00 expecting PGNY to rise to within 12 months (a possible 103.87% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Progyny (NASDAQ: PGNY) is $29.43 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Progyny.
Progyny’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Progyny.
Progyny is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.